Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative

DJ DeSalvo; S Lanzinger; N Noor; Claudia Steigleder-Schweiger; O Ebekozien; S Von Sengbusch; NHY Jones; K Laubner; DM Maahs; RW Holl

doi:10.1089/dia.2022.0248

Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative

DJ DeSalvo
, S Lanzinger
, N Noor
, Claudia Steigleder-Schweiger (Co-author)
, O Ebekozien
, S Von Sengbusch
, NHY Jones
, K Laubner
, DM Maahs
, RW Holl

Department of Pediatrics

Research output: Contribution to journal › Short comment / notes › peer-review

23 Citations (Web of Science)

Original language	English
Pages (from-to)	920-924
Journal	DIABETES TECHNOLOGY & THERAPEUTICS
Volume	24
Issue number	12
DOIs	https://doi.org/10.1089/dia.2022.0248
Publication status	Published - 2022

Access to Document

10.1089/dia.2022.0248

Cite this

DeSalvo, DJ., Lanzinger, S., Noor, N., Steigleder-Schweiger, C., Ebekozien, O., Von Sengbusch, S., Jones, NHY., Laubner, K., Maahs, DM., & Holl, RW. (2022). Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. DIABETES TECHNOLOGY & THERAPEUTICS, 24(12), 920-924. https://doi.org/10.1089/dia.2022.0248

@article{c7ccda89929e499ea7c8c26e4c12b9b5,

title = "Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative",

author = "DJ DeSalvo and S Lanzinger and N Noor and Claudia Steigleder-Schweiger and O Ebekozien and \{Von Sengbusch\}, S and NHY Jones and K Laubner and DM Maahs and RW Holl",

note = "Steigleder-Schweiger: Department of Paediatrics, Paracelsus Medical University, Salzburg, Austria.",

year = "2022",

doi = "10.1089/dia.2022.0248",

language = "English",

volume = "24",

pages = "920--924",

journal = "DIABETES TECHNOLOGY \& THERAPEUTICS",

issn = "1520-9156",

number = "12",

}

DeSalvo, DJ, Lanzinger, S, Noor, N, Steigleder-Schweiger, C, Ebekozien, O, Von Sengbusch, S, Jones, NHY, Laubner, K, Maahs, DM & Holl, RW 2022, 'Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative', DIABETES TECHNOLOGY & THERAPEUTICS, vol. 24, no. 12, pp. 920-924. https://doi.org/10.1089/dia.2022.0248

Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. / DeSalvo, DJ; Lanzinger, S; Noor, N et al.
In: DIABETES TECHNOLOGY & THERAPEUTICS, Vol. 24, No. 12, 2022, p. 920-924.

Research output: Contribution to journal › Short comment / notes › peer-review

TY - JOUR

T1 - Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative

AU - DeSalvo, DJ

AU - Lanzinger, S

AU - Noor, N

AU - Steigleder-Schweiger, Claudia

AU - Ebekozien, O

AU - Von Sengbusch, S

AU - Jones, NHY

AU - Laubner, K

AU - Maahs, DM

AU - Holl, RW

N1 - Steigleder-Schweiger: Department of Paediatrics, Paracelsus Medical University, Salzburg, Austria.

PY - 2022

Y1 - 2022

U2 - 10.1089/dia.2022.0248

DO - 10.1089/dia.2022.0248

M3 - Short comment / notes

C2 - 35947079

SN - 1520-9156

VL - 24

SP - 920

EP - 924

JO - DIABETES TECHNOLOGY & THERAPEUTICS

JF - DIABETES TECHNOLOGY & THERAPEUTICS

IS - 12

ER -

DeSalvo DJ, Lanzinger S, Noor N, Steigleder-Schweiger C, Ebekozien O, Von Sengbusch S et al. Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. DIABETES TECHNOLOGY & THERAPEUTICS. 2022;24(12):920-924. doi: 10.1089/dia.2022.0248